NASDAQ:CLSD

Clearside Biomedical, Inc Earning Date

USA |NASDAQ |USD

CLSD Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.08 $-0.11 $-0.05
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $2.58M $780.00K $3.43M

Clearside Biomedical, Inc's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

CLSD Earnings Date & History Chart

CLSD Earnings & Revenue Forecast

CLSD Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $0.17 $-0.09 $0.33
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-0.15 $-0.42 $0.06
Dec 2022 6 $-0.39 $-0.54 $-0.15

CLSD Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.17 $0.14 $0.14
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.15 $-0.21 $-0.21
Dec 2022 0 / 0 $-0.39 $-0.48 $-0.48

CLSD Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 6 $17.78M $860.00K $29.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $21.05M $2.45M $34.80M
Dec 2022 6 $8.10M $0.00 $19.57M

CLSD Earnings Date & Revenue History

CLSD Earnings History

|
Show More
Show More

CLSD Revenue History

|
Show More
Show More

Clearside Biomedical, Inc Next Earnings Date & Report

CLSD Next Earnings Date & Report Preview: Sep 2021 (FQ)

CLSD's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 6 analysts, the average EPS estimation for Clearside Biomedical, Inc's next quarterly earnings is $-0.08, with a low EPS estimation of $-0.15, and a high estimation of $0.03.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.08, the last 2 month trend is $-0.09, and the 3 month trend is $-0.09.

Based on 6 analysts, the average revenue estimation is $2.58M, with a low revenue estimation of $30.00K, and a high estimation of $9.10M.

Clearside Biomedical, Inc Previous Earnings Dates & Reports

CLSD Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Clearside Biomedical, Inc's previous earnings date was Aug 10, 2021 for its fiscal quarter ended Jun 30, 2021.

CLSD's earnings per share (EPS) was $-0.11, beating the consensus analysts forecast of $-0.13 by 14.26%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -15.38%, and higher than the same period a year before (Jun 2020) by -15.38%.

Revenues were $780.00K, better than the forecast of $780.00K by 0.00%, up by 2194.12% from the previous quarter , and up by 120.34% from the same period last year.

The company reported a net income of $-6.09M.

Free cash flow for the quarter was $-6.95M , compared to $-5.56M last quarter and $-3.22M a year before.

CLSD ended the quarter with $838.00K in total debt, a decrease of -8.52% compared to the previous quarter, and a decrease of -60.45% compared to the same quarter a year before.

CLSD Previous Earnings Date & Report Recap: Dec 2020 (FY)

Clearside Biomedical, Inc's previous annual earnings date was Mar 10, 2021 for its fiscal year ended Dec 31, 2020.

CLSD's earnings per share (EPS) was $-0.39, missing the consensus analysts forecast of $-0.35 by 11.43% , and higher than the previous year's EPS (Dec 2019) by -57.21%.

Revenues were $7.89M, better than the forecast of $7.58M by 4.14%, and up by 263.28% from previous year's revenue.

The company reported a net income of $-18.21M.

Clearside Biomedical, Inc reported a free cash flow of $-13.18M for its fiscal year, compared to $-27.09M a year ago.

The company ended the fiscal year with $1.98M in total debt, a decrease of -64.04% compared to the previous year.